Wegovy 1.7 mg

Wegovy 1.7 mg contains Semaglutide 1.7 mg, a once-weekly GLP-1 receptor agonist prescribed for chronic weight management in adults with obesity or overweight who have at least one weight-related health condition. It is used in combination with a reduced-calorie diet and increased physical activity to support long-term weight management. The 1.7 mg dose is generally an intermediate step in the recommended dose-escalation schedule before reaching the maintenance dose of 2.4 mg.

Semaglutide works by mimicking the natural GLP-1 hormone, helping regulate appetite, increase feelings of fullness, reduce hunger, and slow gastric emptying. These actions contribute to lower calorie intake and support sustainable weight loss. Wegovy is administered as a once-weekly subcutaneous injection and should only be used under the supervision of a qualified healthcare professional.

Manufactured under stringent quality standards, Wegovy 1.7 mg is supplied by trusted pharmaceutical exporters to licensed importers, distributors, wholesalers, hospitals, and healthcare institutions worldwide. We provide export-quality packaging, complete regulatory documentation, competitive wholesale pricing, and reliable global shipping for regulated and semi-regulated markets.